Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomised double-blind two-period crossover study to investigate the effect of treatment with repeat doses of a PPAR gamma agonist on the allergen-induced late asthmatic response in subjects with mild asthma compared with repeat doses of placebo.
rosiglitazone
RES104385
NCT00318630
Asthma
Phase 1
 
September 2013

Powered by ideaPoint, Inc.